Cargando…
Hematopoietic Stem Cell Gene Therapy for Cystinosis: From Bench-to-Bedside
Cystinosis is an autosomal recessive metabolic disease that belongs to the family of lysosomal storage disorders. The gene involved is the CTNS gene that encodes cystinosin, a seven-transmembrane domain lysosomal protein, which is a proton-driven cystine transporter. Cystinosis is characterized by t...
Autor principal: | Cherqui, Stephanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699556/ https://www.ncbi.nlm.nih.gov/pubmed/34943781 http://dx.doi.org/10.3390/cells10123273 |
Ejemplares similares
-
Deficiency of the sedoheptulose kinase (Shpk) does not alter the ability of hematopoietic stem cells to rescue cystinosis in the mouse model
por: Goodman, Spencer, et al.
Publicado: (2021) -
An Update on Translating Stem Cell Therapy for Stroke from Bench to Bedside
por: Dailey, Travis, et al.
Publicado: (2013) -
Identification and Characterisation of the Murine Homologue of the Gene Responsible for Cystinosis, Ctns
por: Cherqui, Stéphanie, et al.
Publicado: (2000) -
CDG Therapies: From Bench to Bedside
por: Brasil, Sandra, et al.
Publicado: (2018) -
Advancing stem cell therapy from bench to bedside: lessons from drug therapies
por: Srijaya, Thekkeparambil Chandrabose, et al.
Publicado: (2014)